chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Around 9:30pm I started feeling nauseas and was having really bad chills to the point of shaking. My fingertips were also becoming numb and tingly. I left work arrived home by 11pm. At this point I had a coat and 3 blankets and was shaking uncontrollably because I still felt so cold. My temperature was 102.5. By 1am most of the shaking subsided but I was experiencing severe muscle aches in my legs and my temperature was now 103.2. Woke up at 5 am and vomited. Checked temperature again and it was coming down. 10am next morning temp was down to 101. Stayed that way almost all day 9/21 accompanied my headache and body aches. Today 9/22 temp is normal but still having painful muscle aches in legs and headaches. Severe chills and shakes Numbness in fingers Muscle aches - legs and back Fever of 103.2 Nausea  Vomiting
COVID vaccinated patient admitted for COVID pneumonia who subsequently died.  Provider discharge note:  "62yo female with PMHx significant for HLD, CKD3, HLD, GERD, DM2 who presented to the ED with progressively worsening cough. She went to a funeral on 10/21 and later found out 8 people who were at the funeral had COVID. Later that day she also developed a cough which has got progressively more productive of white to tan secretions then developed shaking chills. She did receive the Moderna COVID vaccines in December and January 2021. Patient was admitted to the hospital for sepsis and acute on chronic respiratory failure 2/2 COVID-19 pneumonia. She initially was alternating between BiPAP and HFNC. She was treated with Remdesivir and decadron, as well as Rocephin and doxycycline for possible superimposed bacterial infection. Patient's respiratory status progressively worsened to the point where she became altered and required intubation in the ED. CCU was consulted for further management and patient was transferred to the CCU. The following day, patient noted to have decreased UOP, worsening kidney function, and increased secretions in ETT overnight. Febrile to 39.1C. Patient noted to have new left pleural effusion on CXR. Lasix 80mg IV TID ordered. Nephrology consulted. Patient on CRRT overnight. On 11/8, patient was noted to be hypotensive overnight requiring phenylephrine.  Continue on CRRT. Patient's family was consulted for update on worsening status. They arrived at the ICU and made the decision to withdraw care.  Pressors and paralytics were discontinued. Patient was extubated at 1427. Time of death was 1437."
day p/vax pt exp severe erythema, temp 106f, irritable, crying & c/o pain in arm. fever continued for 2days at 102-104f. 7/24 pt improving, low grade temp
Possible administration of expired dose of Moderna; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Possible administration of expired dose of Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jun-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Possible administration of expired dose of Moderna). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Possible administration of expired dose of Moderna) outcome was unknown.            No concomitant medication information was provided. Patient reported that the expiry was on Jun 2022. No treatment medication were provided.
4hr post vax diarrhea, fever, aches, dizzy, a lot of pain;
Pentacel vaccine 08/08/08. + Pertussis culture 9/9/08.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 51 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 22Sep2021 16:00 (Lot number: EW0196) at the age of 51 years as dose 2, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 28Aug2021, for Covid-19 immunization. The following information was reported: NAUSEA (non-serious) with onset 22Sep2021, outcome "recovered", described as "I felt very nauseous"; FEELING ABNORMAL (non-serious) with onset 22Sep2021, outcome "recovered", described as "I could not get out of bed; I felt really bad"; SLUGGISHNESS (non-serious) with onset 22Sep2021, outcome "recovered", described as "I still feel little sluggish; I really was having a hard time this morning"; HEADACHE (non-serious) with onset 22Sep2021, outcome "recovered", described as "I had a terrible headache"; MALAISE (non-serious) with onset 22Sep2021, outcome "recovered", described as "I felt like, I am going to get sick"; ANXIETY (non-serious) with onset 22Sep2021, outcome "recovered", described as "I was concerned"; DIZZINESS (non-serious) with onset 22Sep2021, outcome "recovered", described as "dizzy". Additional information: The patient had received second dose of the vaccine at one of the churches and patient was concerned because when patient got the first vaccine on 28Aug patient was okay, but the second one all on 22Sep2021, patient got it about 4 O'clock and last night and early this morning she is felt very nauseous. The patient felt like, patient was going to get sick, patient had a terrible headache, it is that she could not get out of bed, but after that she is fine because right now she is fine. Is that normal to have a reaction like that, after because patient did not had after the first one but the second one she felt really, really bad. No follow-up attempts are possible. No further information is expected.
The night of administration she complained of severe headaches and ringing in the ears and a burning sensation in the head. She is still at the same level but also now lightheaded and nauseated.
Swollen left arm. Sinuses inflamed with heavy mucus. Throat infamed.   I was afraid the mucus would travel into my lungs.  Went to health facility the 25th of February to phyician`s assistant for medical care.
Patients received a Moderna vaccine past the 30 day use by date; Patients received a Moderna vaccine past the 30 day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received a Moderna vaccine past the 30 day use by date) and PRODUCT STORAGE ERROR (Patients received a Moderna vaccine past the 30 day use by date) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received a Moderna vaccine past the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patients received a Moderna vaccine past the 30 day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received a Moderna vaccine past the 30 day use by date) and PRODUCT STORAGE ERROR (Patients received a Moderna vaccine past the 30 day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. On 26-Jan-2022 vial was stored in refrigerator Reporter stated not sure the temperature excursion was happened or not Treatment information was not provided.
pt recvd vax 25OCT95 & 26OCT c/o swollen lymph glands w/tenderness in lt axilla;flu vax given in lt arm;no further details known as the date of this report;
12 hours after my vaccine I had a fever of 101.7 which lasted about 24 hours. This fever was partnered with a severe headache affecting lower forehead and the back of my head. Full body joint pain in knees shoulders, hips and back. The joint pain lasted for several weeks. I also had lymph node pain around my mid-section which lasted about 7-10 days. Brain fog lasting 4-5 days. I mentioned these symptoms to my Acupuncturist, and he changed her regimen to accommodate my symptoms. I saw my primary care physician on 04/15/2021. She suggested I try physical therapy and ordered an x-ray for my knee which was performed on 04/16/2021. I did see a sports medicine doctor on 04/22/2021. He started me on hyaluronic injection in my knee. I had a series of three injections 04/22/21, 04/29/21, and 05/06/2021. He also ordered an MRI. Within the next few weeks, I started experiencing muscle fasciculation of the left arm and glutes. That last about 1.5 months. I also developed a scalp psoriasis. I had crusting scabs and red blotches that appeared on my head with dry white scales. I had an appointment with a Rheumatologists on 05/28/2021 did bloodwork which did not have any rheumatological markers. He ended up referring me to a dermatologist. I saw a dermatologist on 06/14/2021. The scalp psoriasis was still present at the time of the appointment but was not as prominent. I was prescribed medicated shampoos. It took until July 2021 to resolve. I had a follow up with the sport medicine doctor on 06/07/2021 was referred to an orthopedic surgeon. I did see the surgeon on 06/24/2021 who recommended a total knee replacement. I had the left knee replacement surgery on 09/20/2021. Two weeks after my knee replacement I had right hip pain and muscle spasms in the gluteal area. 10/21/2021 I had a follow up with surgeon after my knee replacement. I requested to have an x-ray of both hips and my right knee which was bothering me. The result was bone on bone osteoarthritis of the right hip. Determined the pain in the right knee was caused by pain in the right hip. I met with the surgeon on 11/09/2021 he told me that I would need a total hip replacement. He recommended I was to follow up in 01/2022. I was scheduled to have a total hip replacement which just occurred on 03/02/2022.
Extreme tiredness starting at about 3 hours after the vaccination.  Then about 8 hours after the vaccination got really cold, freezing, unlike another coldness I've felt.  Feet and toes were especially cold to the touch.  Shivering, heart palpitations too.  Bloating and stomach ache and nausea.  Tiredness continues the day after (today)
Having difficulty walking without teetering and falling into things, hard to walk in straight line; Extremely nauseous; dizzy in waves; No appetite; I nearly black out and fall over if I get up quickly.  I have already fallen and cut myself twice; I nearly black out and fall over if I get up quickly.  I have already fallen and cut myself twice; Weak; fatigued; Manic mood disturbances; flu-like symptoms; This is a spontaneous report from a contactable consumer(patient). This 32-year-old female Consumer (patient) reported for herself. A 32-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Lot Number: EW0169) via an unspecified route of administration in arm left on 21Apr2021 13:30 as dose 2, single (age at vaccination: 32 years) for COVID-19 immunisation. Medical history included Brain aneurysms (coiled and stented), bipolar type 1, migraines, all from an unknown date and unknown if ongoing. Concomitant medications included lithium (LITHIUM); lamotrigine (LAMICTAL); diazepam (VALIUM); risperidone (RISPERIDONE); ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE), all taken for an unspecified indication, start and stop date were not reported. The patient previously took buspar, predenisone and experienced known allergies Buspar, prednisone. Historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Solution for injection Lot Number: ER8733) via an unspecified route of administration in arm left on 01Apr2021 01:45 pm as dose 1, single (age at vaccination: 32 years) for COVID-19 immunisation. No other vaccine in four weeks. No COVID prior vaccination and did not test COVID post vaccination. On 22Apr2021 12:00am, it was reported that the patient experienced having difficulty walking without teetering and falling into things, hard to walk in straight line. Extremely nauseous and dizzy in waves. No appetite. I nearly black out and fall over if I get up quickly, already fallen and cut myself twice, weak and fatigued, manic mood disturbances. This is persisting after the initial flulike symptoms have gotten better. No treatment was received. The clinical outcome of the event was not resolved.  No follow up attempts are possible. No further information is expected
Patient experiencing pain on one side of the body starting this past Monday from her foot all the way to her injection site. Explains she feels extremely hot and achy in all of her joints, but mainly on one side of the body.
Rec'd 'KINRIX' at O.V. on 05-25-16. C/from mom on 5-27-16 to report s/s began 5-26-16, erythema and edema 3 x 2 1/2" to (Rt) arm. C/o tightness. No fever or streaking. Seen at PCN on 5/28/16. Tx = continue MOTRIN and BENADRYL prn.
Grandmother called to report that the patient had a few pustules on 10/20/15 and today 10/21/2015 patient is covered "from head to toe" with pustules. Grandmother states she called CDC today 10/21/2015.
Information has been received from a physician concerning a 15 month old male with no pertinent medical history and no allergies who on 05-MAR-2009 was vaccinated with the first dose of VARIVAX (Oka/Merck) (lot# 660668/1380X). Other suspect vaccine received on 05-MAR-2009 included MMR II (Wistar RA 27/3) (lot # 661675/1505X) (rHA). There was no concomitant medication. Within four hours after receiving the vaccinations the patient experienced vomiting and decreased appetite. The patient recovered from vomiting and decreased appetite within 8 hours of vaccination. Lot checks have been requested.  This is in follow-up to report(s) previously submitted on 5/15/2009. Standard lot check investigations were performed. All in-process quality checks for the lot number 660668/1308X and 661675/1505X in question were satisfactory. The lots met the requirements of the Center for Biologics Evaluation and Research and were released. This is one of several reports from the same source. Additional information has been requested.
Extreme abdominal cramping, akin to contractions during labor (experienced this at first shot as well). Blisters in mouth. Full body weakness, barely able to move.
Intense Chest Pain / Difficulty Breathing / Pericarditis Diagnosed in ER
After about 2 weeks after receiving the first vaccine, I started experiencing some chest tightness on the left side, felt increased pulse on left arm, left side chest, left side of chest.  I have not felt any pain but the chest tightness and pulse are irritating and concerning.  I still have these sensations today on 6/4, almost a month after the first vaccine.
It appears that I received .5mls and not .25mls  from looking at insurance claim. My husband presented the card for my prior vaccinations and explained that this was supposed to be my 4th should (booster) for immunocompromised. They seems a bit confused at first but provided assurances that I would get the right dose. We suspect that already had the vile drawn based on insurance or Immunization Registry (neither of which is correct). I received to much vaccine and am having severe side effects include severely swollen, red, hot, tight arm from shoulder to elbow with blisters; severe joint pain and swelling (to include hips, knees, toes, shoulders, elbows, back pain); bladder inflammation with difficulty urinating; fevers, etc.
Information has been received regarding a case in litigation from a lawyer and the administrator for the estate of an approximately 85 year old male patient. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On an unknown date in 2015, the patient was administered the ZOSTAVAX (lot number, dosage and route of administration not provided) by a pharmacist at a pharmacy. On an unknown date in 2015, the patient was treated by a healthcare provider at a hospital for the following injuries resulting from his ZOSTAVAX use: Shingles. The outcome of the shingles is unknown. The patient died on 24-DEC-2017. The cause of the patient's death is unknown. It is unknown if an autopsy was performed. The patient claims damages as a result of: injury to themselves, wrongful death, survivorship action, and economic losses. Upon internal review, death was determined to be medically significant. Additional information has been requested.; Reported Cause(s) of Death: Death.
pt recv vax 8SEP98;pt devel fever of 103 4SEP98 noc as well as vomitting & faituge;mom gave APAP & notified pediatrician office;pt devel rash all over body;seen by MD & dx allerg rxn;
No adverse event reported. Vaccine administered outside the BUD. Manufacturer supported exclusion. No re-administration required.
Urticarial rash. Rx: PREDNISONE, moisturizers.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 23May2020 at 13:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 43 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Intractable back pain." (unspecified if ongoing). Concomitant medication(s) included: MORPHINE oral, start date: 01Jan2020. Past drug history included: Neurontin for known allergies: neurontin, notes: known allergies: neurontin; Gabapentin for known allergies: Gabapentin, notes: known allergies: Gabapentin; Nsaids for known allergies: Nsaids, notes: known allergies: Nsaids.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: product COVID 19 Treatment brand Paxlovid treatment start date: 11Dec2022, treatment stop date: 13Dec2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Morning after receiving vaccine- severe dizziness, chills, nausea, worst headache I have ever experienced on the left side of head radiating from the base of skull to the front of head, severe fatigue, temp 101 F.  Symptoms much improved two days post vaccine.
Information has been received from the patient's sister referring to a male patient of unknown age. The patient's medical history included splenectomy in 2002 or 2003. The patient's concurrent condition and concomitant therapy were not reported. Since an unknown date in 2002, following the splenectomy, every 5 years for the past 15 years, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot#, expiration date and route not reported). (Product use issue). The patient was due for his next injection of PNEUMOVAX 23 sometime next year. No adverse effect was reported. Additional information has been requested.
This spontaneous report was received from a physician via company representative refers to a female patient of unknown age. The patient's medical history and concurrent conditions were not reported. On an unknown dates, several years ago, the patient was vaccinated with a dose of GARDASIL (4) (dose, route of administration and anatomical location was not reported). Concomitant medications were unspecified by reporter. On an unspecified dates, after administration of the GARDASIL, the patient left the physician's office and fainted in the parking lot and fractured her skull. It was unspecified if the patient was required any medical attention or not. The reporting physician stated that the patient was not his patient. The outcome of the events was unknown. The causal relationship between the events and GARDASIL was not provide. No further information was reported. Upon internal review, fractured her skull was determined to be medically significant. Additional information has been requested.
Delayed injection reaction "covid arm" 8 days post injection. Raised, red, itchy, mild sore. Silver dollar size (growing?). Ice and monitoring, will go to MD if worsens. IM injection, but may not have reached muscle? Reported as I noted it's a rare SE with moderna and even more so with Pfizer.
No soreness, woke up next day with red arm, 4-5 inch redness on upper arm, little if no swelling, not warm to touch, no other reaction
got COVID after first dose of the vaccine; got COVID after first dose of the vaccine; This is a spontaneous report received from a contactable consumer (patient herself). A female patient of an unspecified age received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine), dose 1 via an unspecified route of administration on 17Jan2021 (Batch/Lot Number: EM0477) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient received the first dose of the Pfizer COVID-19 vaccine on 17Jan2021, then she got COVID on an unspecified date after the vaccine and has not received second dose at this time. She wanted to know where she can get the second dose, she knows she is over due for the second dose, was supposed to be received on 15Mar2021. Patient wanted to know if she can have her second dose after 6 weeks, local system is impossible because she got her first dose abroad. The outcome of the event was unknown.   No follow-up attempts are needed. No further information is expected.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 32-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Rosacea in July 2016. Concomitant products included VITAMIN D3 for COVID-19, NAPROXEN for Cramps, VITAMIN B6 for Nausea, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]) for Pregnancy.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Nov-2020 and the estimated date of delivery was 05-Sep-2021. On 28-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.